Trial Profile
To Evaluate the efficacy of Liraglutide on albuminuria reduction in Hypertensive obese patients withType 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Aug 2015
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Aug 2015 New trial record
- 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.